Market Research Logo

United States Pharmaceuticals and Healthcare Report Q2 2015

124 Pages BMI Research March 18, 2015 SKU: BMI5496920

United States Pharmaceuticals and Healthcare Report Q2 2015

BMI View: The US pharmaceutical market's status as the most lucrative globally is unassailable. This is due to unparalleled healthcare access, considerable spending power, a high burden of disease, minimal market access barriers and intense company activity. The key risks to this positive outlook are the increasing influence of pharmacy benefit managers and greater regulation, such as the Branded Prescription Drug Fee.

Headline Expenditure Projections

Pharmaceuticals: USD361.2bn in 2014 to USD372.8bn in 2015; 3.2%growth. Forecast revised upwards from Q115.

Healthcare: USD3,099bn in 2014 to USD3,261bn in 2015; +5.2% growth. Forecast unchanged from Q115.

Show Full Description


Show Table of Contents



United States Pharmaceuticals and Healthcare Report Q2 2015

BMI Research
March 18, 2015

Pricing & Delivery

Report with 3 quarterly updates
$1,295
Report with 3 quarterly updates - 3 User License
$1,945
Report with 3 quarterly updates - 5 User License
$2,500
Report with 3 quarterly updates - Departmental/Site License
$2,995
Global Site License Fulfilled by Publisher
$6,995

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report